The Antitrust Week In Review
Here are some of the developments in antitrust news this past week that we found interesting and are following.
4th Circuit revives antitrust claims against Actelion over Tracleer pricing. The 4th U.S. Circuit Court of Appeals on Tuesday revived a proposed class action against Janssen’s Actelion Pharmaceuticals Ltd accusing the company of extending its patent monopoly on its pulmonary artery hypertension drug...